... Background: Parkinsondisease (PD) is associated with a high prevalence of insomnia, affecting up to 88% of patients. Pharmacotherapy studies in the literature addressing insomnia in PD reveal disappointing ...
... with Parkinsondisease should be a multidisciplinary approach, which includes a coordina- tion of pharmacological and non-pharmacological treat- ment ...with Parkinsondisease ...with ...
... with Parkinsondisease (PD) who have difficulties from side effects or dosing of medications, or both, have the option of undergoing deep brain stimulation ...
... Unified ParkinsonDisease Rating Scale (UPDRS) score in Parkinsondisease (PD) patients who underwent subthalamic nucleus (STN) deep brain stimulation (DBS) 6 years after their surgery and to ...
... Development of cognitive impairment and demen- tia, referred as Parkinsondisease dementia (PDD), is common in PD [8]. The prediction of development of dementia in PD is challenging and of significant ...
... independent Parkinsondisease cohorts with longitudinal ...different disease stages, and some of the definition of outcomes were not identical, we analyzed each cohort separately and combined the ...
... Parkinson’s Disease with only poorly controlled ...the disease, a large prospective cohort study can be ...of Parkinsondisease, an increase of FS is ...of disease) FS ...
... administration, Parkinson related symptomol- ogy does not seem to be affected ...Gaucher disease and Parkinsondisease showed that the chaperone protein was able to reduce substrate accu- ...
... Dementia with Lewy bodies. Related pathologically to PD dementia, DLB is a relatively common cause of dementia. There are diagnostic criteria, but an important feature is development of dementia temporally associ- ated ...
... of disease progression, levodopa therapy may have a complete effect on all signs and symptoms of IPD, leading to a degree of improvement of almost complete tremor, stiffness and ...
... of ion exchange in the cell and, as a result, to the phenomena of aseptic inflammation and edema, causing microtraumatization of muscles, ligamentous apparatus and joint capsules. As a result, the habitual biomechanics ...
... tribution to disease, and to identify high-risk pedigrees informative for predisposition gene identification. This unique Utah resource has enabled our population- based definition of familial clustering observed ...
... Parkinson’s Disease: A Complete Guide for Patients and Family (Hopkins University Press 2nd edition, 2007), and Handbook of Clinical Neurology Hyperkinetic Disorders (Elsevier, 2011); has received honoraria from ...
... Parkinsondisease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP) are degenerative disorders of the CNS that share several common features, especially early in their course, so ...
... WHAT IS DEEP BRAIN STIMULATION? Deep brain stimulation (DBS) is a surgery that is used to treat a number of disabling symptoms of neurologic dis- eases. These include symptoms of Parkinsondisease (PD), ...
... Approximately 75-90% of individuals with Parkinsondisease (PD) have speech and voice disorders at some time in the course of their disease. The most common perceptual speech characteristics include ...
... Finally, in the classic animal model of Parkinsondisease, Faim2 deficient mice displayed a more pronounced loss of TH positive dopaminergic neurons in the substantia nigra than WT. Mice were analyzed 14 ...
... with Parkinsondisease are multifactorial and is related to disease severity, lower extremity co- contractions causing reduced adaptability to postural changes and reduced magnitude of agonistic ...
... The intervention consists of a combination of two soft- ware products. To give people insight into their cogni- tive profile and tailor the intervention towards an individuals’ weaknesses, the participants’ cognitive ...